Publication | Open Access

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)

Hematological MalignancyOncologyHematologyMyeloid NeoplasiaPathologyPhase 2MedicineRadiation OncologyRelapsed/refractory Multiple MyelomaHealth Sciences